Related Experiment Video

Updated: May 28, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

Uncommon yeast infections in hematological patients: from diagnosis to treatment

Morena Caira1, Enrico Maria Trecarichi, Mario Tumbarello

  • 1Hematology Division, Università Cattolica S. Cuore, Largo Francesco Vito, 1, I-00168 Rome, Italy. morena.caira@rm.unicatt.it

Expert Review of Anti-Infective Therapy
|October 28, 2011
PubMed

Insights

Uncommon invasive fungal diseases are increasingly affecting cancer patients, particularly those with hematological malignancies. This review covers epidemiology, diagnosis, and treatment of these challenging infections, including novel antifungal drugs.

Area of Science:

  • Medical Mycology
  • Hematology-Oncology
  • Infectious Diseases

Background:

  • Invasive fungal diseases (IFDs) are a growing concern in cancer patients, especially with hematological malignancies.
  • Aggressive cancer therapies and supportive care contribute to increased IFD incidence.
  • Uncommon fungi are emerging as significant pathogens, causing breakthrough infections with high mortality.

Purpose of the Study:

  • To review the approach to IFDs caused by uncommon yeasts in hematological malignancy patients.
  • To focus on epidemiology, diagnosis, treatment outcomes, and novel antifungal agents.

Main Methods:

  • Literature review and synthesis of current knowledge.
  • Focus on specific uncommon yeasts like Trichosporon, Blastomyces, and Cryptococcus.
  • Discussion of emerging antifungal therapies, including new triazoles and echinocandins.

Main Results:

  • Uncommon yeasts pose a significant threat in this immunocompromised population.
  • Early diagnosis and appropriate treatment are crucial for improving outcomes.
  • Novel antifungal drugs show promise in managing these difficult-to-treat infections.

Conclusions:

  • Hematological malignancy patients with IFDs due to uncommon yeasts require specialized management strategies.
  • Continued research into epidemiology and novel therapeutics is essential.
  • A multidisciplinary approach is key to combating these life-threatening infections.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...